Biologics as cancer treatment modalities.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D007378:Interleukins / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D001688:Biological Products; D003115:Colony-Stimulating Factors; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D007372:Interferons